These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11597521)

  • 1. Recombinant vaccines for hepatitis E.
    Emerson SU; Purcell RH
    Trends Mol Med; 2001 Oct; 7(10):462-6. PubMed ID: 11597521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the development of a hepatitis E vaccine.
    Kamili S
    Virus Res; 2011 Oct; 161(1):93-100. PubMed ID: 21620908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of vaccination against hepatitis E.
    Safary A
    Intervirology; 2001; 44(2-3):162-6. PubMed ID: 11509877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
    Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
    Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine.
    Purcell RH; Nguyen H; Shapiro M; Engle RE; Govindarajan S; Blackwelder WC; Wong DC; Prieels JP; Emerson SU
    Vaccine; 2003 Jun; 21(19-20):2607-15. PubMed ID: 12744897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells.
    Zhang M; Emerson SU; Nguyen H; Engle RE; Govindarajan S; Gerin JL; Purcell RH
    Vaccine; 2001 Dec; 20(5-6):853-7. PubMed ID: 11738749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).
    Purdy MA; McCaustland KA; Krawczynski K; Spelbring J; Reyes GR; Bradley DW
    J Med Virol; 1993 Sep; 41(1):90-4. PubMed ID: 8228944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis E vaccine: WHO position paper, May 2015.
    Wkly Epidemiol Rec; 2015 May; 90(18):185-200. PubMed ID: 25935931
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
    Mazalovska M; Kouokam JC
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from hepatitis E vaccine design.
    Li S; Zhang J; Xia N
    Curr Opin Virol; 2015 Apr; 11():130-6. PubMed ID: 25913817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
    Arankalle VA; Lole KS; Deshmukh TM; Srivastava S; Shaligram US
    Vaccine; 2009 Feb; 27(7):1032-9. PubMed ID: 19095027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of autophagy induction on HEV 239 vaccine immune response in a mouse model.
    Khateri M; Abdoli A; Motevalli F; Fotouhi F; Bolhassani A; Arashkia A; Jazaeri EO; Shahbazi S; Mehrbod P; Naziri H; Aghasadeghi MR
    IUBMB Life; 2018 Mar; 70(3):207-214. PubMed ID: 29369472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new hepatitis E vaccines.
    Cao Y; Bing Z; Guan S; Zhang Z; Wang X
    Hum Vaccin Immunother; 2018; 14(9):2254-2262. PubMed ID: 29708836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques.
    Zhang M; Emerson SU; Nguyen H; Engle R; Govindarajan S; Blackwelder WC; Gerin J; Purcell RH
    Vaccine; 2002 Sep; 20(27-28):3285-91. PubMed ID: 12213398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization.
    Yang S; Wang C; Fang X; Zhai L; Dong C; Ding L; Meng J; Wang L
    Virus Res; 2010 Aug; 151(2):162-9. PubMed ID: 20451569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
    Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.
    Robinson RA; Burgess WH; Emerson SU; Leibowitz RS; Sosnovtseva SA; Tsarev S; Purcell RH
    Protein Expr Purif; 1998 Feb; 12(1):75-84. PubMed ID: 9473460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E vaccine: not a moment too soon.
    Holmberg SD
    Lancet; 2010 Sep; 376(9744):849-51. PubMed ID: 20728933
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis E vaccine development: a 14 year odyssey.
    Wu T; Li SW; Zhang J; Ng MH; Xia NS; Zhao Q
    Hum Vaccin Immunother; 2012 Jun; 8(6):823-7. PubMed ID: 22699438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.